Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

On The Agenda

Sept. 20: Senate HELP Committee Hearing on Laboratory Testing
10 a.m.; 430 Dirksen Senate Office Building, Washington, D.C.
The Senate Health, Education, Labor, and Pensions Committee will hold a hearing on laboratory testing in the era of precision medicine. Witnesses include Weill Medical College of Cornell University Professor of Pathology and Laboratory Medicine David Klimstra and University of Chicago Pritzker School of Medicine Clinical Professor of Pathology Karen Kaul, M.D., Ph.D.

Sept. 21: Senate Subcommittee Hearing on Combatting the Opioid Epidemic
10 a.m.; 342 Dirksen Senate Office Building, Washington, D.C.
The Senate Homeland Security and Governmental Affairs Permanent Subcommittee on Investigations will hold a hearing to review the anti-opioid abuse efforts by federal authorities and private insurers.

Sept. 21: House Committee Hearing on the Price of EpiPens
10 a.m.; 2154 Rayburn House Office Building, Washington, D.C.
The House Oversight and Government Reform Committee will hold a hearing to review the rising price of EpiPens. Mylan, Inc. Chief Executive Officer Heather Bresch and Food and Drug Administration Center for Drug Evaluation and Research Deputy Director Doug Throckmorton, M.D. are expected to testify.

 

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org